TERT and cancer: The Pan-Cancer Analysis of Whole Genomes consortium, investigating 2,658 tumors from 38 cancer diagnoses, highlighted the prevalence of TERT promoter mutations but reported a very limited number of new potential driver events in noncoding regions (7).